[1]
2025. Efficacy of infliximab in autism spectrum disorders in children associated with genetic deficiency of the folate cycle. IMMUNODIAGNOSTICS AND IMMUNOTHERAPY OF NEUROPSYCHIATRIC DISORDERS IN CHILDREN. TECHNOLOGY CENTER PC. 147–157.